Date published: 2025-12-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

KCTD20 Activators

Chemical activators of KCTD20 include a range of compounds that influence intracellular signaling pathways leading to the phosphorylation and subsequent activation of the protein. Forskolin, by activating adenylate cyclase, brings about an increase in cyclic AMP (cAMP) levels which, in turn, activates protein kinase A (PKA). The activation of PKA is a crucial step, as it can directly phosphorylate KCTD20, thereby inducing its functional activation. Similar to Forskolin, Isoproterenol and Epinephrine, both beta-adrenoceptor agonists, initiate a cascade that elevates cAMP and subsequently activates PKA, which can phosphorylate KCTD20. IBMX and Rolipram, through their inhibition of phosphodiesterases, prevent the breakdown of cAMP, ensuring sustained activation of PKA and hence the possibility of KCTD20 activation. PGE2, operating through prostaglandin receptors, and Histamine, via H2 receptors, both promote the increase of cAMP and the activation of PKA, mapping a possible route to the activation of KCTD20.

Further, Dopamine and Salbutamol, through their respective receptor interactions, trigger signaling pathways that culminate in the activation of the cAMP-PKA axis, offering another avenue for the activation of KCTD20. Glucagon, a hormone, binds to its receptor and activates adenylate cyclase, leading to an elevation of cAMP and PKA activity, which can result in the phosphorylation of KCTD20. Cholera toxin, by permanently activating the Gs alpha subunit, causes a continuous increase in cAMP, with the amplified PKA activity potentially leading to the phosphorylation and activation of KCTD20. Anisomycin, while a protein synthesis inhibitor, activates stress-activated protein kinases that can modify transcription factors, potentially altering the expression patterns to favor the activation of KCTD20. Each of these chemicals, through their unique interactions with cellular pathways, ensures the activation of PKA, which serves as a pivotal kinase capable of directly phosphorylating and activating KCTD20.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin activates adenylate cyclase, which increases cAMP levels. Elevated cAMP can enhance the activity of protein kinase A (PKA), which in turn, can phosphorylate KCTD20, leading to its functional activation.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$27.00
$37.00
5
(0)

Isoproterenol is a beta-adrenoceptor agonist that stimulates the production of cAMP via the activation of adenylate cyclase. The rise in cAMP can activate PKA, which may phosphorylate and activate KCTD20.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

IBMX increases intracellular cAMP by inhibiting phosphodiesterases, which degrade cAMP. The accumulation of cAMP activates PKA, which can then phosphorylate and activate KCTD20.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$56.00
$156.00
$270.00
$665.00
37
(1)

Prostaglandin E2 works through G protein-coupled receptors to increase intracellular cAMP, which activates PKA. PKA has the potential to phosphorylate KCTD20, resulting in its activation.

Dopamine

51-61-6sc-507336
1 g
$290.00
(0)

Dopamine can activate dopamine receptors that are coupled to the cAMP-PKA signaling pathway. Activation of this pathway could lead to the phosphorylation and activation of KCTD20.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$40.00
$102.00
$197.00
$1739.00
$16325.00
(1)

Epinephrine interacts with beta-adrenergic receptors to increase cAMP and activate PKA. PKA can then phosphorylate KCTD20, which could lead to its functional activation.

Histamine, free base

51-45-6sc-204000
sc-204000A
sc-204000B
1 g
5 g
25 g
$92.00
$277.00
$969.00
7
(1)

Histamine can bind to H2 receptors that signal through the cAMP-PKA cascade. Activation of this pathway can lead to phosphorylation of KCTD20 by PKA, thus activating the protein.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs). The activation of these kinases could result in the phosphorylation and activation of transcription factors that enhance the expression of proteins like KCTD20.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$75.00
$212.00
18
(1)

Rolipram inhibits phosphodiesterase 4, leading to increased cAMP levels, which activate PKA. PKA could then phosphorylate KCTD20, leading to its activation.

Salbutamol

18559-94-9sc-253527
sc-253527A
25 mg
50 mg
$92.00
$138.00
(1)

Salbutamol is a beta-2 adrenergic agonist that increases intracellular cAMP, thereby activating PKA. PKA potentially phosphorylates and activates KCTD20.